Heart Failure Clinical Trial

Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)

Summary

The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.

View Full Description

Full Description

A fundamental question faced by physicians treating acute decompensated heart failure (ADHF) is "When has treatment worked sufficiently for safe discharge, and who requires further treatment?" Patients with ADHF have a high incidence of morbidity and mortality. Current guidelines for emergency department (ED) and hospital disposition of patients with ADHF are based on limited empirical evidence. This creates clinical uncertainty regarding disposition leads to prolonged hospitalizations, higher costs and increased resource consumption. The specific aim of the study is to develop a prediction rule from readily available clinical data to help physicians identify ADHF patients eligible for safe and early discharge from the ED and hospital after treatment is initiated.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Fulfill the modified Framingham criteria
Have baseline data available within 1 hour of initial ED therapy
Have previously documented systolic dysfunction (ejection fraction less than 50%) by echocardiogram
Willing and able to give informed consent

The exclusion criteria are:

Patients less than 18 years of age.

Study is for people with:

Heart Failure

Estimated Enrollment:

835

Study ID:

NCT00911703

Recruitment Status:

Completed

Sponsor:

Vanderbilt University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

University of Cincinnati
Cincinnati Ohio, 45267, United States
Vanderbilt University
Nashville Tennessee, 37232, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

835

Study ID:

NCT00911703

Recruitment Status:

Completed

Sponsor:


Vanderbilt University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider